The PI3K pathway with its downstream regulators, the serine/threonine kinase AKT and mammalian target of rapamycin (mTOR), has been implicated in the development and progression of many cancers due to its role in mediating cell survival and proliferation. The gene discussed is MTOR; the disease is cancer.